{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:01:10Z","timestamp":1790704870762,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1016\/j.vaccine.2010.01.001","type":"journal-article","created":{"date-parts":[[2010,1,15]],"date-time":"2010-01-15T09:18:18Z","timestamp":1263547098000},"page":"2271-2276","source":"Crossref","is-referenced-by-count":55,"title":["Intramuscular inoculation of calves with an experimental Newcastle disease virus-based vector vaccine elicits neutralizing antibodies against Rift Valley fever virus"],"prefix":"10.1016","volume":"28","author":[{"given":"J.","family":"Kortekaas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Dekker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.M.","family":"de Boer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Weerdmeester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.P.M.","family":"Vloet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.A.C. de","family":"Wit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.P.H.","family":"Peeters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.J.M.","family":"Moormann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.vaccine.2010.01.001_bib1","doi-asserted-by":"crossref","first-page":"883","DOI":"10.2460\/javma.234.7.883","article-title":"Rift Valley fever virus","volume":"234","author":"Bird","year":"2009","journal-title":"J Am Vet Med Assoc"},{"issue":"4","key":"10.1016\/j.vaccine.2010.01.001_bib2","first-page":"205","article-title":"The pathology of Rift Valley fever. I. Lesions occurring in natural cases in new-born lambs","volume":"44","author":"Coetzer","year":"1977","journal-title":"Onderstepoort J Vet Res"},{"issue":"1","key":"10.1016\/j.vaccine.2010.01.001_bib3","first-page":"11","article-title":"The pathology of Rift Valley fever. II. Lesions occurring in field cases in adult cattle, calves and aborted foetuses","volume":"49","author":"Coetzer","year":"1982","journal-title":"Onderstepoort J Vet Res"},{"issue":"3","key":"10.1016\/j.vaccine.2010.01.001_bib4","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1086\/345671","article-title":"Epidemic Rift Valley fever in Saudi Arabia: a clinical study of severe illness in humans","volume":"36","author":"Al-Hazmi","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"20","key":"10.1016\/j.vaccine.2010.01.001_bib5","first-page":"803","article-title":"Rift Valley fever in humans in South Africa","volume":"58","author":"McIntosh","year":"1980","journal-title":"S Afr Med J"},{"issue":"3","key":"10.1016\/j.vaccine.2010.01.001_bib6","first-page":"155","article-title":"Rift Valley fever vaccine\u2014antibody and immune response in cattle to a live and an inactivated vaccine","volume":"50","author":"Barnard","year":"1979","journal-title":"J S Afr Vet Assoc"},{"issue":"1","key":"10.1016\/j.vaccine.2010.01.001_bib7","first-page":"45","article-title":"An inactivated rift valley fever vaccine","volume":"48","author":"Barnard","year":"1977","journal-title":"J S Afr Vet Assoc"},{"issue":"10","key":"10.1016\/j.vaccine.2010.01.001_bib8","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.2460\/ajvr.1980.41.10.1559","article-title":"Evaluation of a formalin-inactivated Rift Valley fever vaccine in sheep","volume":"41","author":"Harrington","year":"1980","journal-title":"Am J Vet Res"},{"issue":"6","key":"10.1016\/j.vaccine.2010.01.001_bib9","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/jmv.20624","article-title":"Adverse response of non-indigenous cattle of European breeds to live attenuated Smithburn Rift Valley fever vaccine","volume":"78","author":"Botros","year":"2006","journal-title":"J Med Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2010.01.001_bib10","first-page":"1","article-title":"Rift Valley fever; the neurotropic adaptation of the virus and the experimental use of this modified virus as a vaccine","volume":"30","author":"Smithburn","year":"1949","journal-title":"Br J Exp Pathol"},{"key":"10.1016\/j.vaccine.2010.01.001_bib11","series-title":"Virus Taxonomy: Eighth Report of the International Committee on Taxonomy of Viruses","author":"Fauquet","year":"2005"},{"key":"10.1016\/j.vaccine.2010.01.001_bib12","series-title":"Diseases of Poultry","first-page":"541","article-title":"Newcastle disease and other paramyxovirus infections","author":"Alexander","year":"1997"},{"key":"10.1016\/j.vaccine.2010.01.001_bib13","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1099\/vir.0.18884-0","article-title":"Recombinant Newcastle disease virus as a viral vector: effect of genomic location of foreign gene on gene expression and virus replication","volume":"84","author":"Zhao","year":"2003","journal-title":"J Gen Virol"},{"issue":"18","key":"10.1016\/j.vaccine.2010.01.001_bib14","doi-asserted-by":"crossref","first-page":"10054","DOI":"10.1128\/JVI.78.18.10054-10063.2004","article-title":"A recombinant Newcastle disease virus (NDV) expressing VP2 protein of infectious bursal disease virus (IBDV) protects against NDV and IBDV","volume":"78","author":"Huang","year":"2004","journal-title":"J Virol"},{"issue":"21","key":"10.1016\/j.vaccine.2010.01.001_bib15","doi-asserted-by":"crossref","first-page":"8203","DOI":"10.1073\/pnas.0602566103","article-title":"Engineered viral vaccine constructs with dual specificity: avian influenza and Newcastle disease","volume":"103","author":"Park","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"issue":"21","key":"10.1016\/j.vaccine.2010.01.001_bib16","doi-asserted-by":"crossref","first-page":"8197","DOI":"10.1073\/pnas.0602461103","article-title":"Newcastle disease virus expressing H5 hemagglutinin gene protects chickens against Newcastle disease and avian influenza","volume":"103","author":"Veits","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"issue":"21","key":"10.1016\/j.vaccine.2010.01.001_bib17","doi-asserted-by":"crossref","first-page":"10293","DOI":"10.1128\/JVI.00919-06","article-title":"Nonsegmented negative-strand viruses as vaccine vectors","volume":"80","author":"Bukreyev","year":"2006","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2010.01.001_bib18","first-page":"46","article-title":"Newcastle disease virus as a vaccine vector for humans","volume":"10","author":"Bukreyev","year":"2008","journal-title":"Curr Opin Mol Ther"},{"issue":"21","key":"10.1016\/j.vaccine.2010.01.001_bib19","doi-asserted-by":"crossref","first-page":"13275","DOI":"10.1128\/JVI.79.21.13275-13284.2005","article-title":"Recombinant Newcastle disease virus expressing a foreign viral antigen is attenuated and highly immunogenic in primates","volume":"79","author":"Bukreyev","year":"2005","journal-title":"J Virol"},{"issue":"23","key":"10.1016\/j.vaccine.2010.01.001_bib20","doi-asserted-by":"crossref","first-page":"9788","DOI":"10.1073\/pnas.0703584104","article-title":"Newcastle disease virus, a host range-restricted virus, as a vaccine vector for intranasal immunization against emerging pathogens","volume":"104","author":"DiNapoli","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"10.1016\/j.vaccine.2010.01.001_bib21","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1016\/j.vaccine.2009.01.009","article-title":"Delivery to the lower respiratory tract is required for effective immunization with Newcastle disease virus-vectored vaccines intended for humans","volume":"27","author":"Dinapoli","year":"2009","journal-title":"Vaccine"},{"issue":"21","key":"10.1016\/j.vaccine.2010.01.001_bib22","doi-asserted-by":"crossref","first-page":"11560","DOI":"10.1128\/JVI.00713-07","article-title":"Immunization of primates with a Newcastle disease virus-vectored vaccine via the respiratory tract induces a high titer of serum neutralizing antibodies against highly pathogenic avian influenza virus","volume":"81","author":"DiNapoli","year":"2007","journal-title":"J Virol"},{"issue":"6","key":"10.1016\/j.vaccine.2010.01.001_bib23","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s00705-008-0099-5","article-title":"Experimental infection of calves with Newcastle disease virus induces systemic and mucosal antibody responses","volume":"153","author":"Subbiah","year":"2008","journal-title":"Arch Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2010.01.001_bib24","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.virol.2007.04.014","article-title":"Comparative analysis of the alphavirus-based vectors expressing Rift Valley fever virus glycoproteins","volume":"366","author":"Gorchakov","year":"2007","journal-title":"Virology"},{"issue":"49\u201350","key":"10.1016\/j.vaccine.2010.01.001_bib25","doi-asserted-by":"crossref","first-page":"7181","DOI":"10.1016\/j.vaccine.2006.06.041","article-title":"Protective immune responses induced by different recombinant vaccine regimes to Rift Valley fever","volume":"24","author":"Wallace","year":"2006","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2010.01.001_bib26","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/0042-6822(89)90365-6","article-title":"Baculovirus expression of the M genome segment of Rift Valley fever virus and examination of antigenic and immunogenic properties of the expressed proteins","volume":"170","author":"Schmaljohn","year":"1989","journal-title":"Virology"},{"issue":"6","key":"10.1016\/j.vaccine.2010.01.001_bib27","doi-asserted-by":"crossref","first-page":"5001","DOI":"10.1128\/JVI.73.6.5001-5009.1999","article-title":"Rescue of Newcastle disease virus from cloned cDNA: evidence that cleavability of the fusion protein is a major determinant for virulence","volume":"73","author":"Peeters","year":"1999","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2010.01.001_bib28","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0378-1119(91)90434-D","article-title":"Efficient selection for high-expression transfectants with a novel eukaryotic vector","volume":"108","author":"Niwa","year":"1991","journal-title":"Gene"},{"key":"10.1016\/j.vaccine.2010.01.001_bib29","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1099\/0022-1317-77-5-963","article-title":"Expression of bacteriophage T7 RNA polymerase in avian and mammalian cells by a recombinant fowlpox virus","volume":"77","author":"Britton","year":"1996","journal-title":"J Gen Virol"},{"issue":"8","key":"10.1016\/j.vaccine.2010.01.001_bib30","doi-asserted-by":"crossref","first-page":"4822","DOI":"10.1128\/JVI.67.8.4822-4830.1993","article-title":"The rule of six, a basic feature for efficient replication of Sendai virus defective interfering RNA","volume":"67","author":"Calain","year":"1993","journal-title":"J Virol"},{"issue":"9","key":"10.1016\/j.vaccine.2010.01.001_bib31","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1007\/s007050070059","article-title":"Genome replication of Newcastle disease virus: involvement of the rule-of-six","volume":"145","author":"Peeters","year":"2000","journal-title":"Arch Virol"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2010.01.001_bib32","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.virol.2006.07.035","article-title":"Development and characterization of a Rift Valley fever virus cell-cell fusion assay using alphavirus replicon vectors","volume":"356","author":"Filone","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2010.01.001_bib33","series-title":"Paramyxoviridae: The Viruses and Their Replication","author":"Lamb","year":"1996"},{"key":"10.1016\/j.vaccine.2010.01.001_bib34","series-title":"The Molecular Biology of the Paramyxovirus Genus","author":"Galinski","year":"1991"},{"issue":"1","key":"10.1016\/j.vaccine.2010.01.001_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.micpath.2003.07.003","article-title":"Role of fusion protein cleavage site in the virulence of Newcastle disease virus","volume":"36","author":"Panda","year":"2004","journal-title":"Microb Pathog"},{"issue":"23","key":"10.1016\/j.vaccine.2010.01.001_bib36","doi-asserted-by":"crossref","first-page":"11868","DOI":"10.1128\/JVI.75.23.11868-11873.2001","article-title":"Recombinant Newcastle disease virus as a vaccine vector","volume":"75","author":"Nakaya","year":"2001","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2010.01.001_bib37","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1006\/viro.2000.0618","article-title":"Recovery of a virulent strain of Newcastle disease virus from cloned cDNA: expression of a foreign gene results in growth retardation and attenuation","volume":"278","author":"Krishnamurthy","year":"2000","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2010.01.001_bib38","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1742-4682-1-10","article-title":"Proteomics computational analyses suggest that the carboxyl terminal glycoproteins of Bunyaviruses are class II viral fusion protein (beta-penetrenes)","volume":"1","author":"Garry","year":"2004","journal-title":"Theor Biol Med Model"},{"issue":"4","key":"10.1016\/j.vaccine.2010.01.001_bib39","first-page":"418","article-title":"Interferon induction by Newcastle disease virus in mice","volume":"18","author":"Blach-Olszewska","year":"1970","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"issue":"1","key":"10.1016\/j.vaccine.2010.01.001_bib40","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1089\/jir.1986.6.21","article-title":"Analysis of the interferons induced in mice in vivo and in macrophages in vitro by Newcastle disease virus and by polyinosinic-polycytidylic acid","volume":"6","author":"Brehm","year":"1986","journal-title":"J Interferon Res"},{"issue":"6","key":"10.1016\/j.vaccine.2010.01.001_bib41","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S1074-7613(01)00154-6","article-title":"Interferons alpha and beta as immune regulators\u2014a new look","volume":"14","author":"Biron","year":"2001","journal-title":"Immunity"},{"issue":"19","key":"10.1016\/j.vaccine.2010.01.001_bib42","doi-asserted-by":"crossref","first-page":"10872","DOI":"10.1073\/pnas.1934678100","article-title":"Selective contribution of IFN-alpha\/beta signaling to the maturation of dendritic cells induced by double-stranded RNA or viral infection","volume":"100","author":"Honda","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"10.1016\/j.vaccine.2010.01.001_bib43","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/ni978","article-title":"Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon","volume":"4","author":"Le Bon","year":"2003","journal-title":"Nat Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2010.01.001_bib44","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1084\/jem.191.10.1777","article-title":"Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice","volume":"191","author":"Santini","year":"2000","journal-title":"J Exp Med"},{"issue":"3","key":"10.1016\/j.vaccine.2010.01.001_bib45","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1128\/JVI.80.3.1130-1139.2006","article-title":"Protection against respiratory syncytial virus by a recombinant Newcastle disease virus vector","volume":"80","author":"Martinez-Sobrido","year":"2006","journal-title":"J Virol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10000319?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10000319?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,16]],"date-time":"2025-02-16T19:42:43Z","timestamp":1739734963000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X10000319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":45,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S0264410X10000319"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.01.001","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}